EPIS® Právní systém | Plné znění

XXXXXXXX XXXXXX X XXXXXXXXX XXXXXXXXX (XX) 2017/698

xx xxx 3. xxxxx 2017,

xxxxxx se xxxx xxxxxxxx x xxxxxxxxx xxxxxxxxx (XX) x. 1062/2014 týkající xx pracovního programu xxxxxxxxxxxxxx přezkumu xxxxx xxxxxxxxxxx účinných xxxxx xxxxxxxxxx x xxxxxxxxxx přípravcích, xxxxx jsou xxxxxxx x xxxxxxxx Xxxxxxxxxx parlamentu x Xxxx (EU) x. 528/2012 x xxxxxxxx xxxxxxxxxx xxxxxxxxx xx xxx x xxxxxx xxxxxxxxx

(Xxxx x významem xxx EHP)

XXXXXXXX XXXXXX,

x xxxxxxx xx Smlouvu x xxxxxxxxx Xxxxxxxx xxxx,

x xxxxxxx xx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x Xxxx (XX) č. 528/2012 xx xxx 22. xxxxxx 2012 x xxxxxxxx biocidních xxxxxxxxx xx xxx x xxxxxx xxxxxxxxx (1), x xxxxxxx xx. 89 xxxx. 1 xxxxxxxxx xxxxxxxx,

vzhledem x xxxxx xxxxxxx:

(1)	Xxxxxxxx Komise x xxxxxxxxx xxxxxxxxx (XX) x. 1062/2014 (2) xxxxxxx v příloze XX xxxxxxxxx xxxxxx xxxxxxxxx xxxxxxxxxxx xxxxxxxx xxxxx x xxxx xxxxxxxxx xxxxxxxxxx do xxxxxxxx xxxxxxxx stávajících xxxxxxxxxx xxxxxxxx xxxxx x 4. xxxxx 2014.

(2)

Xxxxx čl. 14 xxxx. 3 nařízení v přenesené xxxxxxxxx (XX) x. 1062/2014 xxxxx kterákoli xxxxx xxxxxxx kombinaci xxxxx x xxxx přípravku zařazenou xx xxxxx 2 xxxxxxx XX xxxxxxxxx xxxxxxxx xx xxxxxxxx xxxxxx xx xxxx xxxxxx uvedeného xxxxxxxx x xxxxxxxx. Od xxxxxxxx xxxxxxx xxxxx xxxxxxxxx xxxx 2 xxxxxxx XX x xx. 14 xxxx. 3 xxxxxxxxx xxxxxxxx x xxxx xxxxxxx xxxxxxxxx rozhodnutí Xxxxxx (XX) 2016/1950 (3) x xxxxxxxxxxx těchto xxxxxxxxx xxxxx x xxxx přípravku.

(3)	Xxxxxxxxx xxxxx a typu xxxxxxxxx, xxxxx byly xxxxxxxx xxxxx xx. 14 xxxx. 3 x xxxxxxxx xxxxxxxxxxx čl. 17 xxxx. 2 xxxxxxxx x xxxxxxxxx xxxxxxxxx (XX) č. 1062/2014, xx xxxx xxx xxxxxxxx xx xxxxx 1 xxxxxxx XX xxxxxxxxx xxxxxxxx a vyňaty x xxxxx 2 xxxxxxx xxxxxxx.

(4)

Xxxxx xx. 16 xxxx. 4 xxxxxxxx v přenesené xxxxxxxxx (XX) x. 1062/2014 xxxx xxxxxxxxxx xxxxx, xxxxx xxxxx mohla kterákoli xxxxx, xxx xxxx xxxxx xxxxxxx příslušnou xxxxxxxxx xxxxxx xxxxx x xxxx xxxxxxxxx, tak xxxxxx. Xxxxx oznámení xxxxx xx. 16 xxxx. 5 xxxxxxxx v přenesené pravomoci (XX) x. 1062/2014, xxxxx xx xxxxxx chlorid-pentahydroxidu xxxxxxxxxxx xxx xxxxxxx x xxxx xxxxxxxxx 2, xxxx xxxxxxx xxxx xxxxxxxxx lhůty a vyhovělo xxxxxxxxxxx xx. 17 xxxx. 2 xxxxxxxx (XX) č. 1062/2014. Xxxx kombinace xxxxx x xxxx xxxxxxxxx proto xxxx být zařazena x xxxxx 1 xxxxxxx XX xxxxxxxxx xxxxxxxx.

(5)	Xxx xxxxxxxxx xxxxxx látky x xxxx xxxxxxxxx xxxxxxx x 3. x 4. xxxx xxxxxxxxxx xx xxx xxx jmenován xxxxxxxxx xxxxxxxxx xxxxx xxxxx xxxxxx 81 xxxxxxxx (XX) x. 528/2012.

(6)	Xxxxxxxxx xxxxxx xxxxx x xxxx xxxxxxxxx, x xxxxxxx xxxx od 4. srpna 2014 xxxxxxx rozhodnutí x xxxxxxxxx xx xxxxxxxxxxx, xxx xxxxxx x xxxxxxxx přezkumu, x xxxxx již nebudou xxxxxxx x xxxxx 1 xxxxxxx II xxxxxxxx x xxxxxxxxx pravomoci (XX) x. 1062/2014.

(7)	Xxxxxxxxx látky x xxxx xxxxxxxxx uvedené v části 2 xxxxxxx XX xxxxxxxx x xxxxxxxxx pravomoci (XX) x. 1062/2014, xxxxx xxxxxx xxxxxxxx xxxxx xx. 14 xxxx. 3 xxxxxxxx x xxxxxxxx, xx měly xxx vyňaty x xxxxx 2 xxxxxxx xxxxxxx. Xxxx 2 xxxxxxx xxxxxxx je proto xxxxxxxxx x xxxx xx xxx xxxxxx.

(8)	X xxxxxxxx toho xx xx xxxx 1 přílohy II xxxxxxxx x xxxxxxxxx xxxxxxxxx (XX) x. 1062/2014 měla xxxx xxxxxxxx XX, xxxxxxx je jedinou xxxxxxxxx xxxxx xxxxxxx XX, x xxxxxx xx xx. 14 odst. 3 x xxxx 1 xxxxxxx XX xx xxxxx xxxxxxx.

(9)	Nařízení x xxxxxxxxx xxxxxxxxx (EU) x. 1062/2014 by proto xxxx xxx odpovídajícím xxxxxxxx změněno,

XXXXXXX XXXX XXXXXXXX:

Xxxxxx 1

Xxxxxxxx v přenesené xxxxxxxxx (XX) x. 1062/2014 se xxxx xxxxx:

1)	X xxxxxx 14 xx xxxxxxx xxxxxxxx 3.

Xxxxxx 17 xx mění xxxxx:

x)	xxxxxxxx 1 xx xxxxxxxxx xxxxx: „1. Oznámení xxxxx xx. 14 xxxx. 2 xxxx xx. 16 odst. 5 xx xxxxxxxxxxx xxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx.“;

x xxxxxxxx 7 xx xxxxxxx x) xxxxxxxxx xxxxx:

„x)	x xxxxxxx, že bylo xxxxxxxx xxxxxxxxxx xxxxx xx. 14 xxxx. 2, agentura xxxxxxxxxx xxxxxxxxxxx informace x xxxxxxxxx xxxxxxxx xx xxxxxxxxxx xxxxxxxxx x xxxxxxxx xxxxxxxx látky;“.

V článku 20 xx xxxxxxx x) x x) xxxxxxxxx xxxxx:

„x)	xxxxx xxxxx xxxxx xxxxxxxx xxxxxxxx xx xxxxxxx xxxxxxxxxxx x xx. 14 odst. 2 xxxxxx xxxxxxxx nebo xxxxx xxxx oznámení předloženo x xxxxxxxxx podle čl. 17 xxxx. 4 xxxx 5 xxxxxx nařízení;

x)	pokud xxxx xxxxxxxx xxxxxxxxxx xx xxxxx xxxxxxxxx v čl. 14 xxxx. 2 tohoto xxxxxxxx x xxxx xxxxxxx xxxxxxxxx xxxxx xx. 17 odst. 5 xxxxxx xxxxxxxx, ale xxxxxxxx xxxxx v oznámení xxxxxxxx xxxxx xxxx xxxxxxxxx xxxxxxxx x xxxxxxx XX xxxxxx xxxxxxxx.“

4)	Xxxxxxx XX xx xxxxxxxxx xxxxxx xxxxxxx xxxxxx xxxxxxxx.

Xxxxxx 2

Xxxx xxxxxxxx xxxxxxxx x xxxxxxxx dvacátým xxxx xx vyhlášení x Xxxxxxx xxxxxxxx Xxxxxxxx unie.

Xxxx xxxxxxxx je xxxxxxx x xxxxx xxxxxxx x xxxxx xxxxxxxxxx ve xxxxx členských xxxxxxx.

V Bruselu xxx 3. února 2017.

Xx Xxxxxx

xxxxxxxx

Xxxx-Xxxxxx XXXXXXX

(1)&xxxx;&xxxx;Xx. xxxx. L 167, 27.6.2012, s. 1.

(2) Nařízení Komise x&xxxx;xxxxxxxxx xxxxxxxxx (XX) č. 1062/2014 xx xxx 4. srpna 2014 xxxxxxxx xx pracovního xxxxxxxx xxxxxxxxxxxxxx přezkumu xxxxx xxxxxxxxxxx účinných xxxxx xxxxxxxxxx v biocidních xxxxxxxxxxx, xxxxx jsou xxxxxxx x&xxxx;xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x&xxxx;Xxxx (EU) x.&xxxx;528/2012 (Xx. věst. X&xxxx;294, 10.10.2014, x.&xxxx;1).

(3)&xxxx;&xxxx;Xxxxxxxxx xxxxxxxxxx Xxxxxx (XX) 2016/1950 xx xxx 4. listopadu 2016 x&xxxx;xxxxxxxxxxx xxxxxxxx biocidních xxxxxxxx xxxxx podle xxxxxxxx Xxxxxxxxxx parlamentu x&xxxx;Xxxx (XX) x.&xxxx;528/2012 (Xx. xxxx. X&xxxx;300, 8.11.2016, x.&xxxx;14).

XXXXXXX

„

XXXXXXX II

XXXXXXXXX XXXXX X XXXX XXXXXXXXX XXXXXXXX XX PROGRAMU XXXXXXXX XXX 3. ÚNORA 2017

Xxxxxxxxx účinné xxxxx x xxxx přípravku xxxxxxxxxxx xx dni 3. xxxxx 2017, s výjimkou xxxxxxxxxx jiných nanomateriálů xxx xxxx, xxxxx xxxx výslovně uvedeny x xxxxxxxxx 1017, 1019 x 1023

Xxxxx položky

Název xxxxx

Členský xxxx xxxxxxxxx

Xxxxx ES

Číslo XXX

xxxxxxxxxxx

200-001-8

50-00-0

5-{[2-(2-xxxxxxxxxxxx)xxxxxx]xxxxxx}-6-xxxxxx-1,3-xxxxxxxxxxx (piperonylbutoxid/PBO)

200-076-7

51-03-6

xxxxxxxx

200-143-0

52-51-7

xxxxxxx

200-578-6

64-17-5

kyselina xxxxxxxx

200-579-1

64-18-6

xxxxxxxx xxxxxxxxxx

200-712-3

69-72-7

xxxxxx-1-xx

200-746-9

71-23-8

xxxxxxxxxxx

200-849-9

75-21-8

xxxxxxxx citronová

201-069-1

77-92-9

xxxxxxxxx xxxxxxxx/2-xxxxxxxxxxxxxxx xxxxxxxx

201-180-5

79-14-1

xxxxxxxx xxxxxxxxxxxx

201-186-8

79-21-0

X-(+)-xxxxxx xxxxxxxx

201-196-2

79-33-4

2-isopropenyl-8,9-dimethoxy- 1,2,6,6a,12,12a-hexahydrochromeno[3,4- b]furo[2,3-h]chromen-6-on (xxxxxxx)

201-501-9

83-79-4

xxxxxxxxx

201-782-8

87-90-1

xxxxxxx-2-xx

201-993-5

90-43-7

113

xxxxxxxxxxxxx/3-xxxxxxxxx-2-xxxx (cinnamaldehyd)

203-213-9

104-55-2

117

xxxxxxxx

203-377-1

106-24-1

122

xxxxxxx

203-474-9

107-22-2

133

hexa-2,4-dienová kyselina (xxxxxxxx xxxxxxx)

203-768-7

110-44-1

154

chlorofen

204-385-8

120-32-1

171

2-xxxxxxxxxxx-1-xx

204-589-7

122-99-6

172

cetylpyridinium-chlorid/1-hexadecylpyridin-1-ium-chlorid

204-593-9

123-03-5

179

xxxx xxxxxxxx

204-696-9

124-38-9

180

(natrium-kakodylát) – xxxxxxx-xxxxxxxxxxxxxxx

204-708-2

124-65-2

185

xxxxxxxxxxxxxx, xxxxx xxx (xxxxx xxx xxxxxxxxxxxxxxx – xxxxxxxxx X) – (X-xxxxx-4-xxxxxxxxxxxx-1-xxxxxxxxxx)

204-854-7

127-65-1

187

xxxxxx-xxxxxxxxxxxxxxxxxxxxxx

204-875-1

128-03-0

188

xxxxxxx-xxxxxxxxxxxxxxxxxxxxxx

204-876-7

128-04-1

195

xxxxxxx-xxxxxxx-2-xxxx

205-055-6

132-27-4

206

xxxxxx

205-286-2

137-26-8

210

xxxxxx-xxxxxxx

205-293-0

137-42-8

227

2-(xxxxxxx-4-xx)xxxxxxxxxxxx (thiabendazol)

205-725-8

148-79-8

235

xxxxxx

206-354-4

330-54-1

239

karbamonitril

206-992-3

420-04-2

253

tetrahydro-3,5-dimethyl-1,3,5-thiadiazin-2-thion (xxxxxxx)

208-576-7

533-74-4

283

terbutryn

212-950-5

886-50-0

288

X-[(xxxxxxxxxxxxxxxxxx)xxxxxxxx]-X-xxxxx- X′,X′-xxxxxxxxxxxxxxxx (xxxxxxxxxxxxx)

214-118-7

1085-98-9

292

[(1,3-xxxxx-1,3,4,5,6,7-xxxxxxxxx-2X- xxxxxxxx-2-xx)xxxxxx]-xxxxx-2,2-xxxxxxxx-3-(2-xxxxxxxxxx-1-xx-1-xx)xxxxxxxxxxx-1- xxxxxxxxxx (x-xxxxx-xxxxxxxxxxxx)

214-619-0

1166-46-7

321

xxxxxxxxxxx

217-129-5

1746-81-2

330

X-(3-xxxxxxxxxxx)-X-xxxxxxxxxxxxx-1,3-xxxxxx (xxxxxx)

219-145-8

2372-82-9

336

N,N′-dimethyl-2,2′-disulfandiyldibenzamid (XXXXX)

219-768-5

2527-58-4

339

1,2-xxxxxxxxxxxxxxx-3(2X)-xx (XXX)

220-120-9

2634-33-5

341

2-methyltetrahydroisothiazol-3(2H)- xx (XXX)

220-239-6

2682-20-4

346

xxxxxxx-xxxxxxxxxxxxxxxxxx xxxxxxxx

220-767-7

51580-86-0

345

xxxxxxx-xxxxxxxxxxxxxxxxxx

220-767-7

2893-78-9

348

xxxxx(xxxxxxxxx)xxxxxxxxxxxxxxx-xxxxx-xxxxxx (XXX)

221-106-5

3006-10-8

359

(xxxxxxxxxxxx)xxxxxxxxxx (xxxxxxx xxxxxxxx xxxxxxxxxxxxxx x xxxxxxxxxxxxxxxx (XXXxxx))

222-720-6

3586-55-8

365

pyridin-2-thiol-1-oxid, xxxxx xxx (xxxxxxxxx xxxxx)

223-296-5

3811-73-2

368

1-(3-xxxxxxxxxx)-3,5,7-xxxxxx-1-xxxxxxxxxxxxxxx-xxxxxxx (CTAC)

223-805-0

4080-31-3

377

1,3,5-xxxx(2-xxxxxxxxxxxx)xxxxxxxxx-1,3,5-xxxxxxx (XXX)

225-208-0

4719-04-4

382

1,3,4,6-xxxxxxxx(xxxxxxxxxxxxx)xxxxxxxxxxxxxxxx[4,5-x]xxxxxxxx-2,5-xxxx (XXXX)

226-408-0

5395-50-6

392

xxxxxxxx-xxxxxxxxxxxx

228-652-3

6317-18-6

393

1,3-xxx(xxxxxxxxxxxxx)-5,5-xxxxxxxxxxxxxxxxxxxx-2,4-xxxx (XXXXX)

229-222-8

6440-58-0

397

didecyldimethylamonium-chlorid (XXXX)

230-525-2

7173-51-5

401

stříbro

231-131-3

7440-22-4

1023

xxxxxxx, xxxx xxxxxxxxxxxx

231-131-3

7440-22-4

405

oxid xxxxxxxx

231-195-2

7446-09-5

424

bromid xxxxx

231-599-9

7647-15-6

432

xxxxxxxx xxxxx

231-668-3

7681-52-9

434

tetramethrin

231-711-6

7696-12-0

439

peroxid xxxxxx

231-765-0

7722-84-1

444

7x-xxxxxxxxxxxx-1X,3X,5X-xxxxxxx[3,4- x]xxxxxx (EDHO)

231-810-4

7747-35-5

450

xxxxxxxx xxxxxxxx

231-853-9

7761-88-8

453

xxxxxxxxxxxxx xxxxx

231-892-1

7775-27-1

455

xxxxxxxx xxxxxxxx

231-908-7

7778-54-3

457

xxxxx

231-959-5

7782-50-5

458

síran amonný

231-984-1

7783-20-2

1016

xxxxxxx xxxxxxxx

232-033-3

7783-90-6

473

xxxxxxxxxx x xxxxxxxxxxx

232-319-8

8003-34-7

491

oxid xxxxxxxxxx

233-162-8

10049-04-4

494

2,2-dibrom-2-kyanacetamid (XXXXX)

233-539-7

10222-01-2

501

xxxxxxxxxxx

234-232-0

10605-21-7

1022

xxxxxxx-xxxxxxxxxxxxx xxxxxxxxx

234-933-1

12042-91-0

515

bromid xxxxxx

235-183-8

12124-97-9

522

zink-1-oxo-1λ5-pyridin-2-thiolát

236-671-3

13463-41-7

524

xxxxxxxxxxxxxxx-xxxxxxxxxxxxxxxx

237-030-0

13590-97-1

526

xxxxxx-xxxxxxx-2-xxxx

237-243-9

13707-65-8

529

xxxxxxxxxxxxxxx

237-601-4

13863-41-7

531

(benzyloxy)methanol

238-588-8

14548-60-8

541

xxxxxxx-4-xxxxx-3-xxxxxxxxxxxxx

239-825-8

15733-22-9

550

5,5′-xxx(4-xxxxxxxxxx)-1,1′-(xxxxx-1,6- xxxx)xxx(xxxxxxxx)-xxx(x-xxxxxxxx) (XXXX)

242-354-0

18472-51-0

554

4-[(xxxxxxxxxxx)xxxxxxxx]-1-xxxxxxxxxxxx

243-468-3

20018-09-1

559

[(xxxxxxxxxxxx-2-xx)xxxxxxxx]xxxxxx-xxxxxxxxxx (XXXXX)

244-445-0

21564-17-0

562

[2-methyl-4-oxo-3-(prop-2-yn-1-yl)cyklopent-2-en-1-yl]-2,2-dimethyl-3-(2-methylprop-1-en-1-yl)cyklopropan-1-karboxylát (xxxxxxxxxxx)

245-387-9

23031-36-9

563

xxxxxx-(X,X)-xxxx-2,4-xxxxxxx (xxxxxx xxxxxxxx)

246-376-1

24634-61-5

566

α,α′,α″-trimethylhexahydro-1,3,5-triazin-1,3,5- triethanol (XXX)

246-764-0

25254-50-6

571

2-xxxxxxxxxxxxxxxxxxxxxxxxx-3-xx (XXX)

247-761-7

26530-20-1

577

xxxxxxxx(xxxxxxxxx)[3-(xxxxxxxxxxxxxxx)xxxxxx]xxxxxxx-xxxxxxx

248-595-8

27668-52-6

588

xxxxxxxxx-5,5-xxxxxxxxxxxxxxxxxxxx-2,4-xxxx (XXXXX/xxxxxxxxxxxxxxxxxxxxxxxxxx)

251-171-5

32718-18-6

590

3-(4-xxxxxxxxxxxxxx)-1,1-xxxxxxxxxxxxxxxx/xxxxxxxxxxx

251-835-4

34123-59-6

597

1-[2-(allyloxy)-2-(2,4-dichlorfenyl)ethyl]imidazol (xxxxxxxx)

252-615-0

35554-44-0

599

X-[(6-xxxxx-2-xxxxxxxxxx[4,5-x]xxxxxxx-3(2X)-xx)xxxxxx]-X,X-xxxxxxxx-xxxxxxxxxxxxx (xxxxxxxxxxx)

252-626-0

35575-96-3

606

[(3-xxxxxxxxxxx)xxxxxxxxxx]-2,2-xxxxxxxx-3-(2-xxxxxxxxxx-1-xx-1-xx)xxxxxxxxxxx-1-xxxxxxxxxx (xxxxxxxxxxx)

254-484-5

39515-40-7

608

xxxxxxxx(xxxxxxxxxx)[3-(xxxxxxxxxxxxxxx)xxxxxx]xxxxxxx-xxxxxxx

255-451-8

41591-87-1

609

xxx- x xxxxx-x-xxxxxxx-3,8-xxxx (xxxx) (xxxxxxxxxx)

255-953-7

42822-86-6

614

(RS)-α-kyano-3-fenoxybenzyl-(1RS)-cis,trans-3-(2,2-dichlorvinyl)-2,2-dimethylcyklopropan-1-karboxylát (xxxxxxxxxxxx)

257-842-9

52315-07-8

618

[1-xxxxxxx-2-xxxxxxxxxx-2-xx-1-xx]-2,2-xxxxxxxx-3-(2-xxxxxxxxxx-1-xx-1-xx)xxxxxxxxxxx-1-xxxxxxxxxx (xxxxxxxxxx)

259-154-4

54406-48-3

619

3-xxxxxxx-2-xx-1-xx-X-xxxxxxxxxxxxx (XXXX)

259-627-5

55406-53-6

620

tetrakis(hydroxymethyl)fosfonium-sulfát (2:1) (THPS)

259-709-0

55566-30-8

648

4,5-xxxxxxx-2-xxxxxxxxxxxxxxx-3(2X)-xx (4,5-xxxxxxx-2-xxxxx-2X-xxxxxxxxxx-3-xx (XXXXX))

264-843-8

64359-81-5

656

xxx(5-xxxxxxxxxxxxxxxx-3-xx)xxxxxx (oxazolidin/MBO)

266-235-8

66204-44-2

667

alkyl(C12-18)dimethylbenzylammoniumchlorid (ADBAC (X12-18))

269-919-4

68391-01-5

671

xxxxx(X12-16)xxxxxxxxxxxxxxxxxxxxxxxxxxxxx (XXXXX/XXX (X12-X16))

270-325-2

68424-85-1

673

xxxxxxxxxxxxxxxxxxxxxx-xxxxxxx (XXXX) (X8-10)

270-331-5

68424-95-3

690

xxxxx(X12-X18)xxxxxx(xxxxxxxx)xxxxxxxx xxxx 1,1-xxxxx-1λ-1,2-xxxxxxxxxxxxxxx- 3(2H)-onu (ADBAS)

273-545-7

68989-01-5

691

xxxxxxx-X-(xxxxxxxxxxxxx)xxxxxxxx

274-357-8

70161-44-3

692

xxxxx(X10–X16)xxxxxxxxxxxxxxxxx

274-687-2

70592-80-2

693

bis(peroxosíran)-bis(síran) xxxxxxxxxxxxx

274-778-7

70693-62-8

701

xxxxxxxxx-xxxxxxxxxxxxxxxx xxxxxxxxxx (MMPP)

279-013-0

84665-66-7

1015

xxxxxxx, Xxxxxxxxxxx xxxxxx, výtažek

283-644-7

84696-25-3

1024

výtažek xxxxxxx z oleje lisovaného xx xxxxxxx x xxxxx xxxxxxxx Xxxxxxxxxxx xxxxxx xxxxxxxxxxx se xxxxxxxxxxxxxx xxxxxx xxxxxxxxx

283-644-7

84696-25-3

724

alkyl (X12-X14)xxxxxxxxxxxxxxxxxxxxxxxxxxxxx (XXXXX (X12-X14))

287-089-1

85409-22-9

725

xxxxx (X12-X14) xxxxxxxx(xxxxxxxxxxx)xxxxxxxxxxxxxxx (ADEBAC (C12-C14))

287-090-7

85409-23-0

731

xxxxxxxxx xxxxxxxxxxxx, Xxxxxxxxxxxxx xxxxxxxxxxxxxxxx, xxxxxxx

289-699-3

89997-63-7

744

xxxxxxxxx xxxxxx, Lavandula xxxxxxx, xxxxxxx/xxxxxxxxxxx olej

294-470-6

91722-69-9

779

xxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxx x X-xxxxx(X12-X14)xxxxxx-1,2-xxxxxxx (xxxxxxxxxxxxx)

403-950-8

164907-72-6

785

6-xxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx (XXX)

410-850-8

128275-31-0

791

2-xxxxx-1,2-xxxxxxxxxxxx-3(2X)-xx (XXXX)

420-590-7

4299-07-4

792

xxxxxxx xxxxxxxxxxxxxxxxxxx (XXXX)

420-970-2

92047-76-2

811

xxxxxxxxxxxxxxxxxxx xxxxxxxx-xxxxx-xxxxxxxxxxx

422-570-3

265647-11-8

794

xxx-xxxxx-2,2-(2-xxxxxxxxxxxx)xxxxxxxxx-1-xxxxxxxxxx (xxxxxxxx)

423-210-8

119515-38-7

797

1-((X)-3-xxxxxxxxxx)-3,5,7-xxxxxx-1-xxxxxxxxxxxxxxxxxxxxxx (xxx-XXXX)

426-020-3

51229-78-8

800

{[2,5-xxxxx-3-(xxxx-2-xx-1-xx)xxxxxxxxxxxx-1-xx]xxxxxx}-2,2-xxxxxxxx-3- (2-methylprop-1-en-1-yl)cyklopropan-1-karboxylát (xxxx xxxxxxxxxxxxx) (imiprothrin)

428-790-6

72963-72-5

807

(X)-1-[(2-xxxxxxxxxxxx-5-xx)xxxxxx]-3- xxxxxx-2-xxxxxxxxxxxxx (xxxxxxxxxxxxx)

433-460-1

210880-92-5

952

Xxxxxxxx xxxxxxxxxx xxxx xxx Xxxxxxxx xxxxxxxxxx 2362, kmen XXXX-1743

xxxxxxxxxxxxxxx

143447-72-7

955

Xxxxxxxx xxxxxxxxxxxxx subsp. xxxxxxxxxxx, xxxxxxx X14, xxxx xxx xxxx XX65-52 x xxxx než kmen XX3 X

xxxxxxxxxxxxxxx

xxxx xxxxxxxxxx

957

Xxxxxxxx subtilis

xxxxxxxxxxxxxxx

xxxx xxxxxxxxxx

939

xxxxxxx xxxxx (xxxxxxxx xxxxxx xxxxxxxx xxxxxxx x xxxxxxxxx sodného in xxxx)

xxxx

xxxx xxxxxxxxxx

813

xxxxxxxxxxxxxx xxxxxxxx

není xxxxxxxxxx

33734-57-5

1014

xxxxxxxx zeolit

není relevantní

xxxx xxxxxxxxxx

152

xxxxxxx produkty 5,5-xxxxxxxxxxxxxxxxxx, 5-xxxxx-5-xxxxxxxxxxxxxxxx x xxxxxx a chlorem (XXXXX)

xxxx k dispozici

není k dispozici

459

xxxxxxx xxxx xxxxx xxxxxxxxxxxx x xxxxxxxx xxxxxxxxxx

není k dispozici

xxxx x xxxxxxxxx

777

xxxxxxx xxxxxxxx 5,5-xxxxxxxxxxxxxxxxxx, 5-ethyl-5-methylhydantoinu x xxxxxxx (DCEMH)

není k dispozici

xxxx x xxxxxxxxx

810

xxxxxxxxxxxxxx sklo s obsahem xxxxxxx

xxxx k dispozici

308069-39-8

824

stříbrno-zinečnatý zeolit

xxxx x xxxxxxxxx

130328-20-0

1013

xxxxxxxx-xxxxxxx xxxxxx

xxxx x xxxxxxxxx

130328-19-7

1017

xxxxxxx xxxxxxxxxxx na xxxxx xxxxxxxxxx (xxxx nanomateriál xx xxxxx stabilního xxxxxxxx x xxxxxxxxxx xxxxxxxxx xx nanoúrovni)

xxxx k dispozici

xxxx x xxxxxxxxx

1019

xxxx xxxxxxxxx (xxxx xxxxxxxxxxxx xxxxxxx xxxxxxxx x xxxxxxxxxx)

xxxx k dispozici

68909-20-6

831

xxxxxxxxx

xxxxxxxxx xx xxxxxxx xxxxxxx

61790-53-2

854

(XX)-3-xxxxx-2-xxxxxx-4-xxxxxxxxxxxx-2-xx-1-xx- (1X,3X;1X,3X)-2,2-xxxxxxxx-3-(2-xxxxxxxxxx-1- xx-1-xx)xxxxxxxxxxx-1-xxxxxxxxxx (xxxx 4 xxxxxxxxxxxxx) (x-xxxxxxxxx)

xxxxxxxxx na xxxxxxx xxxxxxx

231937-89-6

855

(XX)-3-xxxxx-2-xxxxxx-4-xxxxxxxxxxxx-2-xx-1-xx-(1X,3X)-2,2-xxxxxxxx-3-(2-xxxxxxxxxx-1-xx-1-xx)xxxxxxxxxxx-1-xxxxxxxxxx (xxxx 2 xxxxxxxxxxxxx) (xxxxxxxxxx)

xxxxxxxxx na xxxxxxx xxxxxxx

260359-57-7

848

N-[(6-chlor-3-pyridyl)methyl]- N′-kyan-N-methylethanimidamid (xxxxxxxxxxx)

xxxxxxxxx xx ochranu xxxxxxx

160430-64-8

835

xxxxxxxxxxxx/(X)-(3-xxxxxxxxxxx)xxxxxxxxxx-(X)-2-(4-xxxxxxxxxx)-3-xxxxxxxxxxxxxx (esfenvalerát)

přípravek na xxxxxxx xxxxxxx

66230-04-4

843

4-brom-2-(4-chlorfenyl)-1-(ethoxymethyl)-5-(trifluormethyl)pyrrol-3-karbonitril (chlorfenapyr)

přípravek xx xxxxxxx xxxxxxx

122453-73-0

859

polymer N-methylmethanaminu (EINECS 204-697-4) x (xxxxxxxxxxx)xxxxxxxx (EINECS 203-439-8)/xxxxxxxxx xxxxxxxxx chlorid xxxxxx (PQ Xxxxxxx)

xxxxxxx

25988-97-0

863

poly(biguanid-1,5-diylhexan-1,6-diyl) (XXXX)

xxxxxxx

27083-27-8/32289-58-0

868

xxxx(xxxxxxxx-1,5-xxxxxxxxx-1,6-xxxx-xxxxxxxxxxxx)

xxxxxxx

91403-50-8

869

α-[2-(xxxxxxxxxxxxxxxxxxx)xxxxx]-ω-[xxxxxxxxxxx(xxxxxxxxxx)-xxxxxxxxx] (Xxxxxx 26)

xxxxxxx

94667-33-1

872

N-didecyl-N-dipolyethoxyammonium-borát/α, α′ -(didecyliminio)bis[ω-hydropoly(ethylenoxy)]-borát (xxxxxxxxxxx xxxxxx)

xxxxxxx

214710-34-6

“

Plné znění - 32017R0698

Na co čekáte? Nečekejte už ani minutu.
Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.

Plné znění - 32017R0698

Na co čekáte? Nečekejte už ani minutu. Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.

Na co čekáte? Nečekejte už ani minutu.
Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.